200 results on '"Minai, Omar A."'
Search Results
2. Perioperative Risk and Management in Patients With Pulmonary Hypertension
3. Pulmonary Hypertension in COPD: Epidemiology, Significance, and Management: Pulmonary Vascular Disease: The Global Perspective
4. A 45-Year-Old Woman With Systemic Lupus Erythematosus and Progressive Dyspnea
5. Long-term Outcome in a Patient With Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia
6. Predictors of Nocturnal Oxygen Desaturation in Pulmonary Arterial Hypertension
7. VALGANCICLOVIR-ASSOCIATED NEUTROPENIA IN LUNG TRANSPLANT RECIPIENTS
8. OSA IN PATIENTS WITH PULMONARY HYPERTENSION
9. VASOACTIVE THERAPY CAN HELP IMPROVE FUNCTIONAL CAPACITY IN PATIENTS WITH FIBROTIC LUNG DISEASE AND PULMONARY HYPERTENSION
10. LONG-TERM FOLLOW UP AFTER SUCCESSFUL DISCONTINUATION OF PROSTACYCLIN ANALOGUES IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH)
11. MEASURES OF PULMONARY HYPERTENSION (PAH) SEVERITY DO NOT IDENTIFY PATIENTS AT RISK FOR SIGNIFICANT NOCTURNAL HYPOXEMIA (NH)
12. Referral for Lung Transplantation: A Moving Target
13. Pulmonary Nodules in Lung Transplant Recipients: Etiology and Outcome
14. Respiratory Failure and Sepsis Are the Major Causes of ICU Admissions and Mortality in Survivors of Lung Transplants*
15. ETHNICITY AND IgG LEVELS IN LUNG TRANSPLANT RECIPIENTS
16. PULMONARY NODULES IN LUNG TRANSPLANT RECIPIENTS: ETIOLOGY AND OUTCOME
17. Utility of Transbronchial Needle Aspiration in the Diagnosis of Endobronchial Lesions*
18. Scoring System for Screening of Pulmonary Hypertension in Scleroderma: The Dibosa Study
19. Measuring Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Not on Active Treatment (MOTION): A Study of the Effects of Riociguat on Patient-Reported Outcomes and an Exploration of Telemetric Technology in PAH
20. Effect of Long-term Oral Anticoagulation in Pulmonary Arterial Hypertension (PAH)
21. Short-term and Long-term Outcomes in Patients With Scleroderma and IPAH Undergoing Lung Transplant
22. Outcomes of Beta Blocker Use in Pulmonary Arterial Hypertension
23. Predictors of Outcome in Portopulmonary Hypertension
24. Heart Rate Recovery as a Predictor of Clinical Worsening in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Diseases
25. Electrocardiographic Findings Before Death in Pulmonary Hypertension
26. Physician Monitoring of Pulmonary Arterial Hypertension Subjects: Results From a Large U.S. Health Insurance Claims Database
27. The Correlation Between Heart Rate Recovery After 6-Minute Walk Test and FEV 1 and Exercise Performance in Patient With Chronic Obstructive Airway Diseas
28. Causes of Death in Pulmonary Hypertension: Lessons Learned
29. Heart Rate Recovery in Patients With Pulmonary Arterial Hypertension
30. Heart Rate Recovery After 6-Minute Walk Test in Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension
31. Serial Exhaled Nitric Oxide Measurements With a Portable NO Analyzer in Healthy Obstructive Sleep Apnea Patients
32. Does Heart Rate Recovery After a Six-Minute Walk Test Correlate With Prognostic Factors in Scleroderma-Associated Pulmonary Hypertension?
33. PULMONARY HYPERTENSION IN OBESE PATIENTS: AN ANALYSIS OF HEMODYNAMIC DATA
34. PULMONARY HYPERTENSION ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITOR
35. NONCARDIAC SURGICAL OUTCOMES IN PATIENTS WITH ANGIOGRAPHICALLY PROVEN PULMONARY HYPERTENSION
36. PRACTICE PATTERNS REGARDING MANAGING PULMONARY HYPERTENSION IN PATIENTS WITH PARENCHYMAL LUNG DISEASES: RESULTS OF AN ACCP SURVEY
37. PULMONARY VASCULAR CAPACITANCE IS A STRONG PREDICTOR OF MORTALITY IN PATIENTS WITH IDIOPATHIC AND SCLERODERMA-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
38. COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY IN PATIENTS WITH POSTOPERATIVE HYPOXIA AFTER ELECTIVE ABDOMINAL SURGERY
39. HEMODYNAMIC CHARACTERISTICS OF PULMONARY HYPERTENSION IN SLEEP APNEA
40. SYMPTOMATIC NARROWING OR ATRESIA OF BRONCHUS INTERMEDIUS FOLLOWING LUNG TRANSPLANTATION VANISHING BRONCHUS INTERMEDIUS SYNDROME (VBIS)
41. LONG-TERM FOLLOW UP AFTER SUCCESSFUL DISCONTINUATION OF PROSTACYCLIN ANALOGUES IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH)
42. PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) HAVE POOR SLEEP QUALITY
43. RESTLESS LEGS SYNDROME IN LUNG TRANSPLANT RECIPIENTS
44. The Prevalence and Significance of Exertional Hypoxemia in Primary Pulmonary Hypertension (PPH
45. Improvement in 6 Minute Walk Distance During Long-Term Intravenous Epoprostenol (Prostacyclin) Therapy in Patients With Portopulmonary Hypertensio
46. High Exhaled Nitric Oxide (NO) Levels in Lung Transplant Recipients With Allograft Rejectio
47. Relationship of Tacrolimus Levels To Rejection on Transbronchial Biopsies in Lung Transplant Recipient
48. Metastatic Malignant Melanoma: A Rare Manifestatio
49. The Correlation Between Heart Rate Recovery After 6-Minute Walk Test and FEV1 and Exercise Performance in Patient With Chronic Obstructive Airway Diseas
50. Pulmonary Nodules in Lung Transplant Recipients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.